These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8681641)

  • 1. A death associated with therapy for nosocomially acquired multidrug-resistant tuberculosis.
    Weltman AC; DiFerdinando GT; Washko R; Lipsky WM
    Chest; 1996 Jul; 110(1):279-81. PubMed ID: 8681641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The problem of drug resistance in tuberculosis.
    Kahana LM
    Chest; 1996 Jul; 110(1):8-9. PubMed ID: 8681671
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of MDR-TB: is hepatotoxicity a problem?
    Loddenkemper R; Schaberg T
    Int J Tuberc Lung Dis; 2012 May; 16(5):571. PubMed ID: 22507929
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers.
    Maloney SA; Pearson ML; Gordon MT; Del Castillo R; Boyle JF; Jarvis WR
    Ann Intern Med; 1995 Jan; 122(2):90-5. PubMed ID: 7993001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 21-year-old woman with flank pain.
    Siddiqui MA; Thompson RL
    Mayo Clin Proc; 2006 May; 81(5):673-6. PubMed ID: 16706265
    [No Abstract]   [Full Text] [Related]  

  • 6. Multidrug-resistant tuberculosis in patients without HIV infection.
    Telzak EE; Sepkowitz K; Alpert P; Mannheimer S; Medard F; el-Sadr W; Blum S; Gagliardi A; Salomon N; Turett G
    N Engl J Med; 1995 Oct; 333(14):907-11. PubMed ID: 7666876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis.
    Younossian AB; Rochat T; Ketterer JP; Wacker J; Janssens JP
    Eur Respir J; 2005 Sep; 26(3):462-4. PubMed ID: 16135729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multidrug resistant tuberculosis among health personnel in Côte d'Ivoire].
    Bakayoko AS; Ahui BJ; Nguessan R; Kone A; Kone Z; Daix AT; Badoum G; Adou G; Kouakou OA; Kouakou J; Coulibaly G; Domoua K; Aka-Danguy E
    Rev Pneumol Clin; 2016 Apr; 72(2):142-6. PubMed ID: 26651931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increasing transmission of tuberculosis in the world. Multiresistant strains are the greatest threat].
    Tärnvik A
    Lakartidningen; 2000 Nov; 97(48):5590-2. PubMed ID: 11187373
    [No Abstract]   [Full Text] [Related]  

  • 10. Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
    Bhushan B; Chander R; Kajal NC; Ranga V; Gupta A; Bharti H
    Indian J Tuberc; 2014 Oct; 61(4):318-24. PubMed ID: 25675695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nosocomial transmission of human immunodeficiency virus and subsequent transmission of multidrug-resistant tuberculosis in a healthcare worker.
    Ridzon R; Kenyon T; Luskin-Hawk R; Schultz C; Valway S; Onorato IM
    Infect Control Hosp Epidemiol; 1997 Jun; 18(6):422-3. PubMed ID: 9181399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nosocomial transmission of the F15/LAM4/KZN genotype of Mycobacterium tuberculosis in patients on tuberculosis treatment.
    Pillay M; Sturm AW
    Int J Tuberc Lung Dis; 2010 Feb; 14(2):223-30. PubMed ID: 20074415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial transmission of multidrug-resistant tuberculosis.
    Crudu V; Merker M; Lange C; Noroc E; Romancenco E; Chesov D; Günther G; Niemann S
    Int J Tuberc Lung Dis; 2015 Dec; 19(12):1520-3. PubMed ID: 26614195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health systems failing health workers: time for a change.
    Harrington M
    Int J Tuberc Lung Dis; 2010 Aug; 14(8):935-6. PubMed ID: 20626933
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatotoxicity during treatment for multidrug-resistant tuberculosis: occurrence, management and outcome.
    Keshavjee S; Gelmanova IY; Shin SS; Mishustin SP; Andreev YG; Atwood S; Furin JJ; Miller A
    Int J Tuberc Lung Dis; 2012 May; 16(5):596-603. PubMed ID: 22410436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One doctor's misfortune boosts TB treatment activism.
    Bateman C
    S Afr Med J; 2013 Feb; 103(3):134-6. PubMed ID: 23472681
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial outbreak of disseminated multidrug-resistant tuberculosis and meningitis.
    Sofia M; Maniscalco M; Honoré N; Molino A; Mormile M; Heym B; Cole ST
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):551-8. PubMed ID: 11409583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
    Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
    Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study.
    von Gottberg A; Klugman KP; Cohen C; Wolter N; de Gouveia L; du Plessis M; Mpembe R; Quan V; Whitelaw A; Hoffmann R; Govender N; Meiring S; Smith AM; Schrag S;
    Lancet; 2008 Mar; 371(9618):1108-13. PubMed ID: 18359074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
    Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
    Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.